The Global Health Body Raises Warning Over Acute Lack of Obesity Medications
Fewer than 10% of individuals who could benefit from GLP-1 drugs including Wegovy are able to get them, states the World Health Organization as it issues its inaugural recommendations on the medications.
Given in excess of 1,000,000,000 people worldwide now living with obesity, it is urging more widespread and fairer availability to these injectable treatments.
According to estimates, over two billion will be living with obesity by 2030 if no action is taken.
"The new guidelines acknowledges that excess weight is a long-term condition that can be addressed with comprehensive and ongoing care," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and distribution challenges are significant hurdles to widespread access to the treatments that can help people shift considerable weight, notes the organization.
GLP-1 Therapy Supply Crisis
Even in the current most favorable outlook, the production of such drugs would only suffice for approximately 100 million people – under 10% of those who need them, as stated by the health organization.
The guideline urges nations and manufacturers to increase availability, by approaches including patent sharing.
Exclusive production rights on the active ingredient – the core component of the drug Wegovy – is set to lapse in several countries in 2026.
How Weight-Loss Jabs Operate
The injections mimick a natural hormone to slow digestion, suppress the appetite and enhance satiety so individuals eat less.
People usually see weight reduction after several weeks of beginning the weekly injections.
Studies suggests people may see weight return a year later of halting the drug, when their normal appetite resume.
Being above a healthy weight increases your chance for experiencing diseases, like diabetes, cardiovascular issues, brain attack, and some malignancies.
Excess weight concerns individuals in every country and was linked to millions of fatalities worldwide in 2024, per the health agency.
